PYXS SCHEDULE 13G/A: SEC filing
Filed with the SEC on · accession 0000919574-26-006818
PYXS filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Oct 9, 2026. GordonMD Global Investments LP, GordonMD Long Biased Master Fund LP, Craig D. The stock moved +2.0% by the first close after the filing.
Summary of the filing
GordonMD Global Investments LP, GordonMD Long Biased Master Fund LP, Craig D. Gordon, and GordonMD Long Biased GP LLC filed a joint filing agreement as part of an amended Schedule 13G regarding their passive ownership of Pyxis Oncology common stock.
Key details
How PYXS stock reacted
Close before
$1.99
Oct 8, 2026
First close after
+2.01%
$2.03
5 trading days
-9.55%
$1.80
Since filing
-16.58%
$1.66
✦ Ask GOAX AI about this filing — what it means for PYXS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for PYXS?
Click hereFrequently asked questions
What did PYXS file with the SEC on Oct 9, 2026?
PYXS filed a SCHEDULE 13G/A (SEC filing). GordonMD Global Investments LP, GordonMD Long Biased Master Fund LP, Craig D. Gordon, and GordonMD Long Biased GP LLC filed a joint filing agreement as part of an amended Schedule 13G regarding their passive ownership of Pyxis Oncology common stock.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did PYXS stock react to this filing?
PYXS closed at $1.99 before the filing and $2.03 on Oct 9, 2026 (+2.01%). Five trading days later: $1.80 (-9.55%).
Other PYXS SEC filings
- 8-K · SEC filingNov 5, 2026
- 10-Q · SEC filingNov 5, 2026
- SCHEDULE 13G/A · SEC filingNov 3, 2026
- DEF 14A · SEC filingOct 21, 2026
- SCHEDULE 13G · SEC filingOct 5, 2026
- SCHEDULE 13G/A · SEC filingOct 2, 2026
- 424B5 · Secondary offeringOct 1, 2026
- 8-K · Secondary offeringOct 1, 2026
- 8-K · Fda approvalSep 9, 2026
- 8-K · Ceo changeSep 8, 2026
Get alerts when PYXS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days